Stacie Heller
As a Senior Director with nearly twenty years reimbursement related experience working within AmerisourceBergen Specialty Group, Stacie Heller leads Xcenda's Washington, DC-based health policy practice. Stacie is also a member of the editorial board for the Specialty Group's "Health Policy Weekly" publication.
Ms. Heller tracks and analyzes congressional and regulatory health policy and provides the Specialty Group's clients and other stakeholders with ongoing strategic guidance, proactive updates, analysis, and policy briefs related to issues affecting the healthcare industry. Ms. Heller collaborates closely with pharmaceutical, biotech and medical device clients to help their teams develop relationships with senior policy officials and gain an understanding of how coverage and payment issues related to new and existing technologies affect patient access.
Ms. Heller's expertise encompasses a wide range of public payers and includes developing reimbursement strategies for new products and addressing reimbursement obstacles for existing therapies. Previously, Ms. Heller directed the operational management of the reimbursement-based patient assistance programs for HIV/AIDS therapies at the Lash Group. Before joining the Specialty Group, Ms. Heller monitored physician-related reimbursement issues for the American Society of Internal Medicine, now part of the American College of Physicians (ACP).
Ms. Heller received a B.A. in public policy from Pennsylvania State University.
